Nisa Investment Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Nisa Investment Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-280	Closed	-$1K	–	2165
2019 Q4	$1K	Hold	280	–	–	﹤0.01%	2008
2019 Q3	$1K	Hold	280	–	–	﹤0.01%	2007
2019 Q2	$2K	Hold	280	–	–	﹤0.01%	1995
2019 Q1	$4K	Hold	280	–	–	﹤0.01%	1959
2018 Q4	$3K	Hold	280	–	–	﹤0.01%	1896
2018 Q3	$4K	Sell	280 -170	-38%	-$2.53K	﹤0.01%	1917
2018 Q2	$7K	Buy	450 +180	+67%	+$3.14K	﹤0.01%	1807
2018 Q1	$5K	Hold	270	–	–	﹤0.01%	1806
2017 Q4	$6K	Hold	270	–	–	﹤0.01%	1807
2017 Q3	$11K	Hold	270	–	–	﹤0.01%	1735
2017 Q2	$8K	Hold	270	–	–	﹤0.01%	1770
2017 Q1	$10K	Sell	270 -230	-46%	-$10.1K	﹤0.01%	1681
2016 Q4	$25K	Hold	500	–	–	﹤0.01%	1571
2016 Q3	$26K	Hold	500	–	–	﹤0.01%	1569
2016 Q2	$21K	Buy	+500	New	+$21.7K	﹤0.01%	1598

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Nisa Investment Advisors's FPRX Position: Q1 2020 in Review

Nisa Investment Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2020, closing a stake of 280 shares — an estimated $1K sold.

Nisa Investment Advisors first reported a position in FPRX in Q2 2016 and held it in 15 quarters. The position peaked at $26K in Q3 2016. 87 funds tracked by Wall St. Rank hold FPRX as of Q1 2020.

Nisa Investment Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Nisa Investment Advisors sold 280 Five Prime Therapeutics, Inc. shares in Q1 2020, an estimated $1K.
Nisa Investment Advisors first reported a position in Five Prime Therapeutics, Inc. in Q2 2016 and held it in 15 quarters.
Nisa Investment Advisors's Five Prime Therapeutics, Inc. position peaked at $26K in Q3 2016.
87 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2020.

Based on Nisa Investment Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.